| Date |
Inspection Type |
Inspection ID |
Inspection Result |
|
|
May 4, 2026 |
Monitoring |
2026-I-LIRO-047843
|
Violations Found
|
|
|
|
|
| Regulation |
Description |
Compliance Status |
| 416.4(b)(1) |
Evacuation drills must be conducted at least monthly during the hours of operation of the group family day care home. |
Corrected |
| 416.11(a)(2) |
The written medical statement from the health care provider must also state whether the child is a child with special health care needs and, if so, what special provisions, if any, will be necessary in order for the child to participate in child day care. When the written statement from the health care provider advises the day care program that the child being enrolled is a child with special health care needs, the day care program must work together with the parent and the child's health care provider to develop a reasonable health care plan for the child while the child is in the child care program. The health care plan for the child must also address how the day care program will obtain or develop any additional competencies that the caregivers will need to have in order to carry out the health care plan for the child. |
Corrected |
| 416.11(f)(21) |
In the case of medication that needs to be given on an ongoing, long-term basis, the authorization and consent forms for children under the age of 5 years of age must be reauthorized at least once every six months. Any changes in the medication authorization related to dosage, time or frequency of administration shall require a program to obtain new instructions written by the licensed authorized prescriber. All other changes to the original medication authorization require a change in the prescription. |
Corrected |
| 416.11(h)(5) |
When a caregiver has not been authorized to administer medications in a day care setting in accordance with the requirements of subdivision (f) of this section, such caregiver may administer emergency care through the use of patient-specific epinephrine auto-injectors, Diphenhydramine, when prescribed in combination with the auto-injector, asthma inhalers and asthma nebulizers when necessary to prevent anaphylaxis or breathing difficulty for an individual child, but only when the parent and the child's health care provider have indicated such treatment is appropriate. In addition: |
Corrected |
|
|
Feb 18, 2026 |
Annual Unannounced |
2026-I-LIRO-002821
|
No violations cited for this Inspection |
|
|
Oct 27, 2025 |
Monitoring |
2025-I-LIRO-110536
|
No violations cited for this Inspection |
|
|
Jul 30, 2025 |
Monitoring |
2025-I-LIRO-055940
|
No violations cited for this Inspection |
|
|
Apr 9, 2025 |
Annual Unannounced |
2025-I-LIRO-003757
|
No violations cited for this Inspection |
|
|
Oct 8, 2024 |
Monitoring |
2024-I-LIRO-100394
|
No violations cited for this Inspection |
|
|
Jun 4, 2024 |
Monitoring |
2024-I-LIRO-050540
|
No violations cited for this Inspection |
|